Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoantibodies | 23 | 2023 | 103 | 8.180 |
Why?
|
| Antigens, Neoplasm | 18 | 2022 | 59 | 6.940 |
Why?
|
| Carcinoma, Hepatocellular | 12 | 2023 | 145 | 5.030 |
Why?
|
| Liver Neoplasms | 11 | 2023 | 190 | 4.570 |
Why?
|
| Autoantigens | 7 | 2016 | 81 | 2.630 |
Why?
|
| Antibodies, Neoplasm | 7 | 2022 | 16 | 2.440 |
Why?
|
| Autoimmunity | 4 | 2015 | 53 | 1.610 |
Why?
|
| Membrane Proteins | 4 | 2015 | 517 | 1.520 |
Why?
|
| Lung Neoplasms | 4 | 2016 | 358 | 1.520 |
Why?
|
| RNA-Binding Proteins | 3 | 2016 | 146 | 1.400 |
Why?
|
| Nuclear Proteins | 3 | 2016 | 307 | 1.380 |
Why?
|
| Neoplasms | 7 | 2017 | 1103 | 1.300 |
Why?
|
| Esophageal Neoplasms | 2 | 2023 | 127 | 1.220 |
Why?
|
| Immunologic Tests | 6 | 2017 | 11 | 1.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 12 | 2016 | 448 | 1.140 |
Why?
|
| Liver Cirrhosis | 6 | 2023 | 52 | 1.070 |
Why?
|
| Cell Proliferation | 7 | 2023 | 1198 | 1.070 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2015 | 40 | 0.970 |
Why?
|
| Proteomics | 5 | 2016 | 325 | 0.940 |
Why?
|
| Case-Control Studies | 10 | 2016 | 1130 | 0.940 |
Why?
|
| Prostatic Neoplasms | 4 | 2016 | 935 | 0.910 |
Why?
|
| Cell Line, Tumor | 13 | 2023 | 2231 | 0.890 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 88 | 0.880 |
Why?
|
| Humans | 41 | 2023 | 37093 | 0.830 |
Why?
|
| Prostatic Hyperplasia | 3 | 2016 | 34 | 0.800 |
Why?
|
| Gene Expression | 4 | 2015 | 674 | 0.710 |
Why?
|
| ral GTP-Binding Proteins | 2 | 2016 | 8 | 0.650 |
Why?
|
| Breast Neoplasms | 5 | 2016 | 1502 | 0.650 |
Why?
|
| Microarray Analysis | 3 | 2010 | 61 | 0.650 |
Why?
|
| Blotting, Western | 7 | 2016 | 859 | 0.630 |
Why?
|
| Eukaryotic Initiation Factors | 2 | 2015 | 13 | 0.620 |
Why?
|
| Neoplasm Proteins | 3 | 2015 | 213 | 0.590 |
Why?
|
| Sensitivity and Specificity | 6 | 2016 | 562 | 0.580 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2015 | 807 | 0.570 |
Why?
|
| Nerve Tissue Proteins | 3 | 2015 | 360 | 0.570 |
Why?
|
| Signal Transduction | 6 | 2016 | 1908 | 0.570 |
Why?
|
| Apoptosis | 4 | 2023 | 1398 | 0.560 |
Why?
|
| Hepatitis, Chronic | 4 | 2023 | 5 | 0.540 |
Why?
|
| Cell Movement | 3 | 2016 | 571 | 0.530 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2015 | 77 | 0.520 |
Why?
|
| Tissue Array Analysis | 4 | 2016 | 67 | 0.510 |
Why?
|
| BRCA2 Protein | 1 | 2015 | 37 | 0.510 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 127 | 0.510 |
Why?
|
| BRCA1 Protein | 1 | 2015 | 48 | 0.510 |
Why?
|
| Immunohistochemistry | 5 | 2016 | 893 | 0.500 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2015 | 78 | 0.500 |
Why?
|
| Early Detection of Cancer | 2 | 2016 | 336 | 0.500 |
Why?
|
| Cell Adhesion | 1 | 2015 | 212 | 0.490 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2014 | 54 | 0.490 |
Why?
|
| Cyclin B1 | 1 | 2014 | 16 | 0.480 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2016 | 33 | 0.480 |
Why?
|
| Glutathione Transferase | 1 | 2014 | 88 | 0.480 |
Why?
|
| alpha-Fetoproteins | 2 | 2014 | 31 | 0.460 |
Why?
|
| Chemokines, CC | 1 | 2014 | 51 | 0.460 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 155 | 0.460 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2015 | 187 | 0.460 |
Why?
|
| Energy Metabolism | 1 | 2014 | 168 | 0.450 |
Why?
|
| Proteome | 3 | 2022 | 144 | 0.430 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 178 | 0.430 |
Why?
|
| Recombinant Proteins | 4 | 2016 | 515 | 0.420 |
Why?
|
| Aged | 10 | 2016 | 6741 | 0.420 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 269 | 0.420 |
Why?
|
| Female | 16 | 2016 | 20969 | 0.390 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2015 | 213 | 0.380 |
Why?
|
| Middle Aged | 10 | 2016 | 10129 | 0.380 |
Why?
|
| Male | 13 | 2016 | 20025 | 0.380 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 312 | 0.370 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 3 | 2015 | 35 | 0.370 |
Why?
|
| Gene Knockdown Techniques | 3 | 2014 | 173 | 0.350 |
Why?
|
| Cerium | 3 | 2013 | 10 | 0.330 |
Why?
|
| Molecular Biology | 1 | 2009 | 46 | 0.320 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 409 | 0.310 |
Why?
|
| ROC Curve | 3 | 2016 | 138 | 0.300 |
Why?
|
| Calcium-Binding Proteins | 1 | 2007 | 76 | 0.290 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 31 | 0.280 |
Why?
|
| Edwardsiella tarda | 2 | 2015 | 2 | 0.270 |
Why?
|
| Fish Diseases | 2 | 2015 | 4 | 0.260 |
Why?
|
| Neoplasm Staging | 2 | 2016 | 275 | 0.260 |
Why?
|
| Enterobacteriaceae Infections | 2 | 2015 | 11 | 0.260 |
Why?
|
| Nanoparticles | 3 | 2016 | 318 | 0.260 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 539 | 0.260 |
Why?
|
| Genes, myc | 1 | 2005 | 29 | 0.250 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 186 | 0.250 |
Why?
|
| Tumor Stem Cell Assay | 2 | 2014 | 21 | 0.250 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2015 | 189 | 0.240 |
Why?
|
| Prostate-Specific Antigen | 2 | 2016 | 118 | 0.240 |
Why?
|
| Early Diagnosis | 2 | 2014 | 64 | 0.240 |
Why?
|
| Calcium | 1 | 2007 | 480 | 0.240 |
Why?
|
| Transfection | 2 | 2015 | 523 | 0.230 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2023 | 7 | 0.220 |
Why?
|
| Adult | 7 | 2016 | 11712 | 0.220 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 2379 | 0.220 |
Why?
|
| Cytoskeletal Proteins | 1 | 2023 | 105 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2015 | 54 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 448 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 190 | 0.190 |
Why?
|
| Zea mays | 2 | 2012 | 69 | 0.190 |
Why?
|
| Disease Progression | 2 | 2016 | 601 | 0.190 |
Why?
|
| Up-Regulation | 2 | 2015 | 513 | 0.180 |
Why?
|
| Area Under Curve | 2 | 2016 | 88 | 0.170 |
Why?
|
| Prognosis | 2 | 2014 | 739 | 0.170 |
Why?
|
| Young Adult | 3 | 2015 | 4268 | 0.170 |
Why?
|
| Metabolome | 2 | 2015 | 53 | 0.160 |
Why?
|
| Mammography | 2 | 2016 | 188 | 0.150 |
Why?
|
| DNA, Complementary | 2 | 2009 | 191 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2015 | 173 | 0.140 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2016 | 24 | 0.140 |
Why?
|
| Janus Kinase 2 | 1 | 2016 | 32 | 0.140 |
Why?
|
| Glycolysis | 1 | 2016 | 68 | 0.140 |
Why?
|
| Tumor Burden | 1 | 2016 | 77 | 0.140 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2015 | 2 | 0.140 |
Why?
|
| Microvessels | 1 | 2016 | 28 | 0.140 |
Why?
|
| Antibody Formation | 2 | 2006 | 74 | 0.130 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2015 | 18 | 0.130 |
Why?
|
| Quercetin | 1 | 2016 | 45 | 0.130 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2015 | 31 | 0.130 |
Why?
|
| RNA Stability | 1 | 2015 | 26 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2017 | 95 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2015 | 26 | 0.130 |
Why?
|
| Cichlids | 1 | 2015 | 4 | 0.130 |
Why?
|
| Lipid Peroxidation | 2 | 2013 | 140 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 252 | 0.130 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 51 | 0.130 |
Why?
|
| Seroepidemiologic Studies | 1 | 2015 | 68 | 0.130 |
Why?
|
| Autophagy | 1 | 2016 | 116 | 0.130 |
Why?
|
| Myoelectric Complex, Migrating | 1 | 2014 | 1 | 0.130 |
Why?
|
| Hydrogen Peroxide | 2 | 2013 | 190 | 0.130 |
Why?
|
| Prostate | 1 | 2016 | 154 | 0.130 |
Why?
|
| Gastrointestinal Motility | 1 | 2014 | 18 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2015 | 149 | 0.120 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 62 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 108 | 0.120 |
Why?
|
| Bacterial Vaccines | 1 | 2015 | 125 | 0.120 |
Why?
|
| Zebrafish | 1 | 2015 | 128 | 0.120 |
Why?
|
| Paclitaxel | 1 | 2014 | 50 | 0.120 |
Why?
|
| Esophagus | 1 | 2014 | 42 | 0.120 |
Why?
|
| Immunity, Humoral | 1 | 2014 | 24 | 0.120 |
Why?
|
| Isoenzymes | 1 | 2014 | 161 | 0.120 |
Why?
|
| Breast | 1 | 2015 | 135 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 217 | 0.120 |
Why?
|
| Glucose | 1 | 2015 | 230 | 0.110 |
Why?
|
| Immune Sera | 1 | 2013 | 59 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2014 | 399 | 0.110 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2016 | 277 | 0.110 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 55 | 0.110 |
Why?
|
| Alginates | 1 | 2012 | 11 | 0.110 |
Why?
|
| Protein Binding | 1 | 2015 | 972 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 626 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 461 | 0.100 |
Why?
|
| Liver | 1 | 2014 | 479 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 578 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 974 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2012 | 150 | 0.100 |
Why?
|
| Soil Pollutants | 1 | 2012 | 87 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1207 | 0.100 |
Why?
|
| Time Factors | 1 | 2015 | 1742 | 0.090 |
Why?
|
| Retrospective Studies | 1 | 2016 | 2026 | 0.090 |
Why?
|
| Liver Diseases | 1 | 2010 | 33 | 0.090 |
Why?
|
| Antioxidants | 1 | 2013 | 416 | 0.090 |
Why?
|
| Reference Standards | 1 | 2009 | 52 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 935 | 0.090 |
Why?
|
| Metal Nanoparticles | 1 | 2012 | 183 | 0.080 |
Why?
|
| Gene Library | 1 | 2009 | 57 | 0.080 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 325 | 0.080 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 78 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2007 | 143 | 0.070 |
Why?
|
| Animals | 5 | 2016 | 15081 | 0.070 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2005 | 32 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2005 | 85 | 0.060 |
Why?
|
| Plant Shoots | 2 | 2013 | 23 | 0.050 |
Why?
|
| Plant Roots | 2 | 2013 | 158 | 0.050 |
Why?
|
| Adolescent | 1 | 2007 | 5363 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 2015 | 9 | 0.030 |
Why?
|
| Vaccines, Attenuated | 1 | 2015 | 72 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 325 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 337 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 259 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 251 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 260 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 109 | 0.030 |
Why?
|
| Galactosamine | 1 | 2014 | 4 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2015 | 81 | 0.030 |
Why?
|
| Duodenum | 1 | 2014 | 12 | 0.030 |
Why?
|
| Digestion | 1 | 2014 | 16 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 194 | 0.030 |
Why?
|
| Metabolomics | 1 | 2015 | 81 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 661 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 400 | 0.030 |
Why?
|
| Germination | 1 | 2013 | 7 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 583 | 0.030 |
Why?
|
| Chlorophyll | 1 | 2013 | 22 | 0.030 |
Why?
|
| Electrolytes | 1 | 2013 | 25 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 66 | 0.030 |
Why?
|
| Fluorescence | 1 | 2013 | 121 | 0.030 |
Why?
|
| Drug Tolerance | 1 | 2012 | 40 | 0.030 |
Why?
|
| Materials Testing | 1 | 2012 | 69 | 0.030 |
Why?
|
| Hexuronic Acids | 1 | 2012 | 5 | 0.030 |
Why?
|
| Glucuronic Acid | 1 | 2012 | 5 | 0.030 |
Why?
|
| X-Ray Absorption Spectroscopy | 1 | 2012 | 7 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2015 | 753 | 0.030 |
Why?
|
| Surface Properties | 1 | 2012 | 130 | 0.030 |
Why?
|
| Soil | 1 | 2012 | 130 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2013 | 938 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3483 | 0.020 |
Why?
|